Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Launay

Showing results (161-170 of 307) with videos related to

Pageof 31
Sort By:
Joint Bone Spine|July 13, 2020
Extended myositis-specific and -associated antibodies profile in systemic sclerosis: A cross-sectional studyAmélie Leurs, Sylvain Dubucquoi, François Machuron, et al.
Frontiers in Immunology|July 18, 2022
Effects of Immunoglobulins G From Systemic Sclerosis Patients in Normal Dermal Fibroblasts: A Multi-Omics StudyAurélien Chepy, Solange Vivier, Fabrice Bray, et al.
Journal of the Neurological Sciences|October 10, 2009
Effective immune restoration after immunosuppressant discontinuation in a lupus patient presenting progressive multifocal leukoencephalopathyGuillaume Lefèvre, Viviane Queyrel, Claude-Alain Maurage, et al.
Respiration; International Review of Thoracic Diseases|March 1, 2018
Association between Rheumatoid Arthritis and Pulmonary Hypertension: Data from the French Pulmonary Hypertension RegistryDavid Montani, Julien Henry, Caroline O'Connell, et al.
Respiratory Research|October 15, 2022
Mild pulmonary hemodynamic alterations in patients with systemic sclerosis: relevance of the new 2022 ESC/ERS definition of pulmonary hypertension and impact on mortalitySébastien Puigrenier, Jonathan Giovannelli, Nicolas Lamblin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 16, 2018
Ulnar Artery Occlusion and Severity Markers of Vasculopathy in Systemic Sclerosis: A Multicenter Cross-Sectional StudyAlain Lescoat, Cécile Marie Yelnik, Guillaume Coiffier, et al.
Medicine|August 19, 2016
A nationwide study of acquired C1-inhibitor deficiency in France: Characteristics and treatment responses in 92 patientsDelphine Gobert, Romain Paule, Denise Ponard, et al.
Frontiers in Immunology|August 15, 2022
Soluble markers of B cell activation suggest a role of B cells in the pathogenesis of systemic sclerosis-associated pulmonary arterial hypertensionSébastien Sanges, Thomas Guerrier, Alain Duhamel, et al.
Journal of Critical Care|June 13, 2026
Intensive care admissions for severe immune-related adverse events associated with immune checkpoint inhibitor therapy: a 10-year cohort studySamuel Pichon, Ghadi Zebian, Charlotte Lacombe, et al.
Frontiers in Immunology|January 13, 2018
Value of the Overall Pneumococcal Polysaccharide Response in the Diagnosis of Primary Humoral ImmunodeficienciesBenjamin Lopez, Mathilde Bahuaud, Claire Fieschi, et al.
Pageof 31

Showing results (161-170 of 307) with videos related to

Sort By:
Pageof 31
Joint Bone Spine|July 13, 2020
Extended myositis-specific and -associated antibodies profile in systemic sclerosis: A cross-sectional studyAmélie Leurs, Sylvain Dubucquoi, François Machuron, et al.
Frontiers in Immunology|July 18, 2022
Effects of Immunoglobulins G From Systemic Sclerosis Patients in Normal Dermal Fibroblasts: A Multi-Omics StudyAurélien Chepy, Solange Vivier, Fabrice Bray, et al.
Journal of the Neurological Sciences|October 10, 2009
Effective immune restoration after immunosuppressant discontinuation in a lupus patient presenting progressive multifocal leukoencephalopathyGuillaume Lefèvre, Viviane Queyrel, Claude-Alain Maurage, et al.
Respiration; International Review of Thoracic Diseases|March 1, 2018
Association between Rheumatoid Arthritis and Pulmonary Hypertension: Data from the French Pulmonary Hypertension RegistryDavid Montani, Julien Henry, Caroline O'Connell, et al.
Respiratory Research|October 15, 2022
Mild pulmonary hemodynamic alterations in patients with systemic sclerosis: relevance of the new 2022 ESC/ERS definition of pulmonary hypertension and impact on mortalitySébastien Puigrenier, Jonathan Giovannelli, Nicolas Lamblin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 16, 2018
Ulnar Artery Occlusion and Severity Markers of Vasculopathy in Systemic Sclerosis: A Multicenter Cross-Sectional StudyAlain Lescoat, Cécile Marie Yelnik, Guillaume Coiffier, et al.
Medicine|August 19, 2016
A nationwide study of acquired C1-inhibitor deficiency in France: Characteristics and treatment responses in 92 patientsDelphine Gobert, Romain Paule, Denise Ponard, et al.
Frontiers in Immunology|August 15, 2022
Soluble markers of B cell activation suggest a role of B cells in the pathogenesis of systemic sclerosis-associated pulmonary arterial hypertensionSébastien Sanges, Thomas Guerrier, Alain Duhamel, et al.
Journal of Critical Care|June 13, 2026
Intensive care admissions for severe immune-related adverse events associated with immune checkpoint inhibitor therapy: a 10-year cohort studySamuel Pichon, Ghadi Zebian, Charlotte Lacombe, et al.
Frontiers in Immunology|January 13, 2018
Value of the Overall Pneumococcal Polysaccharide Response in the Diagnosis of Primary Humoral ImmunodeficienciesBenjamin Lopez, Mathilde Bahuaud, Claire Fieschi, et al.
Pageof 31